Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Expanded use of Photofrin approved by FDA

Jan. 4, 1999

Ajinomoto prepares potent, water-soluble combretastatin analogues

Dec. 30, 1998

IND filed by Cell Pathways for new SAAND; lead compound Prevatac enters clinic for sixth indication

Dec. 30, 1998

Water-soluble anticancer compounds available for licensing from NIH

Dec. 30, 1998

Several NDAs up for review by FDA oncologic advisory committee in January

Dec. 30, 1998

Grant to help Faulding and collaborators develop innovative prostate cancer treatment

Dec. 29, 1998

Vion pursues prodrugs of 3-AP with superior biological, pharmaceutical properties

Dec. 29, 1998

Resveratrol shown to bind to and cleave DNA

Dec. 29, 1998

U.S. clinical trials of SU-6668 slated for early 1999

Dec. 29, 1998

Isis obtains antisense cancer rights from Genzyme Molecular Oncology

Dec. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...